Forte Biosciences | 4:持股变动声明-董事 GRYSKA DAVID W
Forte Biosciences | 4:持股变动声明-董事 Eichenfield Lawrence
Forte Biosciences | 4:持股变动声明-董事 Kornfeld Steven
Forte Biosciences | 4:持股变动声明-董事 Doberstein Stephen K
Forte Biosciences | 4:持股变动声明-董事 FINCK BARBARA K
Forte Biosciences | 4:持股变动声明-董事 Brun Scott C.
Forte Biosciences | 4:持股变动声明-董事 Williams Donald Allen
Forte Biosciences | 4:持股变动声明-高管 Riley Antony A
Forte Biosciences | 4:持股变动声明-高管 Wagner Paul A.
Forte Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-ATG Fund II LLC(4.0%),ATG Capital Management, LLC(4.0%)等
Forte Biosciences | 4:持股变动声明-高管 Riley Antony A
Forte Biosciences | 4:持股变动声明-高管 Wagner Paul A.
Forte Biosciences | 4:持股变动声明-董事 FINCK BARBARA K
Forte Biosciences | 4:持股变动声明-高管 Riley Antony A
Forte Biosciences | 4:持股变动声明-高管 Wagner Paul A.
Forte Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(9.9%),Joseph Edelman(9.9%)等
Forte Biosciences | SC 13G:超过5%持股股东披露文件-TYBOURNE CAPITAL MANAGEMENT (HK) LIMITED(9.99%),TYBOURNE STRATEGIC OPPORTUNITIES GP II LIMITED(9.99%)等
Forte Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Alger Associates, Inc.(5.1%)
Forte Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Joshua J. Dapice(9.9%),Philip D. Dreyfuss(9.9%)等
Forte Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-BML Investment Partners, L.P.(4.8%)
暂无数据